Zealand Pharma A/S ZLDPF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 722.75M | 1.41B | 1.40B | 1.39B | 1.39B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 722.75M | 1.41B | 1.40B | 1.39B | 1.39B |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 58.30K | -917.20K |
| Gross Profit | 722.75M | 1.41B | 1.40B | 1.39B | 1.39B |
| SG&A Expenses | 78.55M | 77.38M | 75.48M | 83.18M | 67.11M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 200.00 | 26.62M | 29.72M | 29.72M | 29.72M |
| Total Operating Expenses | 365.05M | 380.78M | 349.44M | 310.87M | 282.52M |
| Operating Income | 357.70M | 1.03B | 1.05B | 1.08B | 1.10B |
| Income Before Tax | 440.93M | 1.05B | 1.07B | 1.09B | 1.11B |
| Income Tax Expenses | 15.46M | 83.29M | 83.15M | 87.34M | 81.26M |
| Earnings from Continuing Operations | 425.47 | 967.99 | 982.44 | 999.94 | 1.02K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 425.47M | 967.99M | 982.44M | 999.94M | 1.02B |
| EBIT | 357.70M | 1.03B | 1.05B | 1.08B | 1.10B |
| EBITDA | 362.18M | 1.03B | 1.06B | 1.09B | 1.11B |
| EPS Basic | 6.05 | 13.68 | 13.88 | 14.13 | 14.48 |
| Normalized Basic EPS | 3.80 | 9.21 | 9.29 | 9.54 | 9.70 |
| EPS Diluted | 6.00 | 13.45 | 13.66 | 13.91 | 14.25 |
| Normalized Diluted EPS | 3.76 | 9.06 | 9.14 | 9.39 | 9.55 |
| Average Basic Shares Outstanding | 281.61M | 281.99M | 282.06M | 282.44M | 282.80M |
| Average Diluted Shares Outstanding | 282.05M | 282.98M | 283.05M | 283.43M | 283.79M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |